How GLP-1s changed Thanksgiving
Obesity medications are diminishing appetites for the foods that American holidays are known for
Related reading
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
Can WeightWatchers stay relevant when everyone is on diet drugs?
GLP-1 medications could be the group’s death knell — or grant it a new lease on life
Eli Lilly shot helped patients lose 29% of body weight
Trial results are a boost to US pharmaceutical company’s booming obesity business
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of…
Weight-loss jabs push sugar price to five-year low
Futures price has fallen to less than half its level in late 2023 as GLP-1s reduce cravings for sweet snacks
Weight-loss drugs are bringing a new commercial reality
The reinforcing feedback loop that has long powered the food industry is being chemically switched off